1)Eaden JA, Abrams KR, Mayberry JF, et al. The risk of colorectal cancer in ulcerative colitis. A meta-analysis. Gut 48:526-535, 2001
2)Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130:1030-1038, 2006
3)Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis:a case-control study. Gastroenterology 130:1941-1949, 2006
4)Rutter MD, Saunders BP, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis:endoscopic appearances help predict cancer risk. Gut 53:1813-1816, 2004
5)Mutaguchi M, Naganuma M, Sugimoto S, et al. Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients.Dig Liver Dis 51:1257-1264, 2019
6)Sugimoto S, Shimoda M, Iwao Y, et al. Intramucosal poorly differentiated and signet-ring cell components in patients with ulcerative colitis-associated high-grade dysplasia. Dig Endosc 31:706-711, 2019
7)Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3:special situations. J Crohns Colitis 7:1-33, 2013
8)下田将之,岩男泰,亀山香織,他.消化管粘膜内腫瘍の見方,考え方,そのエビデンス—炎症性腸疾患.病理と臨 37:741-747, 2019
9)Sugimoto S, Naganuma M, Iwao Y, et al. Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement. Gastrointest Endosc 85:639-646, 2017
10)Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology 151:1122-1130, 2016
11)岩男泰,下田将之,三上修治,他.炎症性腸疾患の拡大内視鏡診断—腫瘍.胃と腸 51:690-699, 2016